- Home
- CCBG vs ARCT Comparison
CCBG vs ARCT Comparison
Compare CCBG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- ARCT
- Stock Information
- Founded
- CCBG 1895
- ARCT 2013
- Country
- CCBG United States
- ARCT United States
- Employees
- CCBG N/A
- ARCT N/A
- Industry
- CCBG Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- ARCT Health Care
- Exchange
- CCBG Nasdaq
- ARCT Nasdaq
- Market Cap
- CCBG 625.1M
- ARCT 487.0M
- IPO Year
- CCBG N/A
- ARCT N/A
- Fundamental
- Price
- CCBG $37.72
- ARCT $15.88
- Analyst Decision
- CCBG Buy
- ARCT Strong Buy
- Analyst Count
- CCBG 2
- ARCT 8
- Target Price
- CCBG $39.00
- ARCT $61.00
- AVG Volume (30 Days)
- CCBG 26.6K
- ARCT 405.9K
- Earning Date
- CCBG 01-28-2025
- ARCT 03-06-2025
- Dividend Yield
- CCBG 2.47%
- ARCT N/A
- EPS Growth
- CCBG 1.63
- ARCT N/A
- EPS
- CCBG 3.12
- ARCT N/A
- Revenue
- CCBG $230,883,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CCBG N/A
- ARCT $7.33
- Revenue Next Year
- CCBG $3.97
- ARCT $4.71
- P/E Ratio
- CCBG $11.94
- ARCT N/A
- Revenue Growth
- CCBG 4.53
- ARCT N/A
- 52 Week Low
- CCBG $25.45
- ARCT $14.30
- 52 Week High
- CCBG $40.86
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CCBG 58.74
- ARCT 41.74
- Support Level
- CCBG $35.44
- ARCT $16.03
- Resistance Level
- CCBG $37.91
- ARCT $17.95
- Average True Range (ATR)
- CCBG 1.08
- ARCT 1.29
- MACD
- CCBG 0.25
- ARCT -0.07
- Stochastic Oscillator
- CCBG 92.10
- ARCT 10.29
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.